Keywords: ProStrakan, Abstral, FDA approval, Sancuso, EvaluatePharma

Painful wait for ProStrakan on Abstral’s US approval

Article | 18 August 2010

Print This

Following the recent US Food and Drug Administration delay in approving ProStrakan’s Abstral (The Pharma Letter June 3), the company ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in